Skip to content
10-Q

Quarterly Report

Landos Biopharma, Inc.

0000950170-23-040165

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 3.12M sh
Shares Diluted Q2 2023 · Jun 30, 2023 6.21M sh
Shares Diluted Q2 2023 · Jun 30, 2023 6.35M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 4.03M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 4.03M sh
Stock Repurchased Q2 2023 · Jun 30, 2023 $3M
Stock Repurchased Q2 2023 · Mar 31, 2023 $3M
Stock Repurchased Q2 2023 · Jun 30, 2022 $0
Capex Q2 2023 · Jun 30, 2023 $0
Capex Q2 2023 · Jun 30, 2022 $7K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$13.28M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$34.5M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $44.05M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $36.64M
Stockholders Equity Q2 2023 · Jun 30, 2023 $43.27M
Stockholders Equity Q2 2023 · Mar 31, 2023 $47.02M
Stockholders Equity Q2 2023 · Dec 31, 2022 $39.13M
Stockholders Equity Q2 2023 · Jun 30, 2022 $51.53M
Stockholders Equity Q2 2023 · Mar 31, 2022 $62.1M
Stockholders Equity Q2 2023 · Dec 31, 2021 $76.27M
Current Liabilities Q2 2023 · Jun 30, 2023 $3.02M
Current Liabilities Q2 2023 · Dec 31, 2022 $6.12M
Total Liabilities Q2 2023 · Jun 30, 2023 $3.02M
Total Liabilities Q2 2023 · Dec 31, 2022 $6.12M
Current Assets Q2 2023 · Jun 30, 2023 $46.29M
Current Assets Q2 2023 · Dec 31, 2022 $45.25M
Total Assets Q2 2023 · Jun 30, 2023 $46.29M
Total Assets Q2 2023 · Dec 31, 2022 $45.25M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.63
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.57
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$2.80
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$6.50
Eps Basic Q2 2023 · Jun 30, 2023 −$0.63
Eps Basic Q2 2023 · Jun 30, 2023 −$1.57
Eps Basic restated Q2 2023 · Jun 30, 2022 −$2.80
Eps Basic restated Q2 2023 · Jun 30, 2022 −$6.50
Sga Expense Q2 2023 · Jun 30, 2023 $1.98M
Sga Expense Q2 2023 · Jun 30, 2023 $5.13M
Sga Expense Q2 2023 · Jun 30, 2022 $4.66M
Sga Expense Q2 2023 · Jun 30, 2022 $8.82M
Rd Expense Q2 2023 · Jun 30, 2023 $2.46M
Rd Expense Q2 2023 · Jun 30, 2023 $5.79M
Rd Expense Q2 2023 · Jun 30, 2022 $6.6M
Rd Expense Q2 2023 · Jun 30, 2022 $17.4M
Net Income Q2 2023 · Jun 30, 2023 −$3.92M
Net Income Q2 2023 · Jun 30, 2023 −$9.96M
Net Income Q2 2023 · Mar 31, 2023 −$6.03M
Net Income Q2 2023 · Jun 30, 2022 −$11.28M
Net Income Q2 2023 · Jun 30, 2022 −$26.15M
Net Income Q2 2023 · Mar 31, 2022 −$14.86M
Operating Income Q2 2023 · Jun 30, 2023 −$4.44M
Operating Income Q2 2023 · Jun 30, 2023 −$10.92M
Operating Income Q2 2023 · Jun 30, 2022 −$11.27M
Operating Income Q2 2023 · Jun 30, 2022 −$26.22M